MedTrace Logo

Pulmonary Fibrosis Foundation Patient Registry

NCT02758808 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2004

Last updated 2023-07-07

No results posted yet for this study

Summary

The Pulmonary Fibrosis Foundation Patient Registry will collect data on at least 2,000 patients with interstitial lung disease (ILD) at approximately 40 clinical sites in the US. The Registry is targeting enrollment of approximately 60% of the 2,000 ILD participants to have idiopathic pulmonary fibrosis (IPF). The aim of the Registry is to create a cohort of well-characterized patients with interstitial lung disease (ILD) for participation in retrospective and prospective research

Conditions

  • Interstitial Lung Disease (ILD)
  • Idiopathic Pulmonary Fibrosis (IPF)

Sponsors & Collaborators

Principal Investigators

  • Kevin R Flaherty, MD · University of Michigan

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-29
Primary Completion
2022-12-16
Completion
2022-12-16

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02758808 on ClinicalTrials.gov